- NERV Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Minerva Neurosciences (NERV) 8-K1 May 23Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in SchizophreniaFinancial data
Company Profile